Related content

A metaanalysis of randomized controlled trials comparing early and late concurrent thoracic radiotherapy with etoposide and cisplatin/carboplatin chemotherapy for limiteddisease smallcell lung cancer

By          

Molecular and Clinical Oncology, Vol. 2, Iss. 5, 2014-01 ,pp. : 805-810

Spandidos Publications

Access to resources Recommend Favorite

Efficacy of chemotherapy plus gefitinib treatment in advanced nonsmallcell lung cancer patients following acquired resistance to gefitinib

By    

Molecular and Clinical Oncology, Vol. 1, Iss. 5, 2013-01 ,pp. : 875-878

Spandidos Publications

Access to resources Recommend Favorite

Phase II study on the combination of irinotecan plus cisplatin as a secondline therapy in patients with advanced or recurrent gastric cancer

By                    

Molecular and Clinical Oncology, Vol. 1, Iss. 4, 2013-01 ,pp. : 749-752

Spandidos Publications

Access to resources Recommend Favorite

Docetaxel-based therapy with and without antiangiogenic agents as first-line chemotherapy for castration-resistant prostate cancer: A meta-analysis of nine randomized controlled trials

By              

Molecular and Clinical Oncology, Vol. 2, Iss. 6, 2014-01 ,pp. : 1182-1188

Spandidos Publications

Access to resources Recommend Favorite

Phase II study of concurrent chemoradiotherapy with carboplatin and vinorelbine for locally advanced non-small-cell lung cancer

By                          

Molecular and Clinical Oncology, Vol. 2, Iss. 3, 2014-01 ,pp. : 405-410

Spandidos Publications

Access to resources Recommend Favorite